The DOI matches its Crossref record; 83 of the 84 references it cites were found in a registry or an index.
X-Linked Adrenoleukodystrophy: Pathogenesis and Treatment
Abstract
X-linked adrenoleukodystrophy (X-ALD) is a puzzling inborn error of metabolism with a strikingly heterogeneous clinical spectrum. All patients have mutations in the ABCD1 gene and accumulate very long chain fatty acids in all tissues. Virtually all male X-ALD patients develop adrenocortical insufficiency in childhood and progressive myelopathy and peripheral neuropathy in adulthood. A subset of male patients, however, develops a fatal cerebral demyelinating disease, cerebral adrenoleukodystrophy. Female patients also develop progressive myelopathy and peripheral neuropathy, but generally at a later age than males. They only very rarely develop adrenocortical insufficiency or cerebral adrenoleukodystrophy. This review proposes to simplify the classification of the clinical spectrum of X-ALD and reviews the largely unresolved pathophysiological mechanisms and the current treatment options.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Nonetheless, identical variants can result in highly diverse clinical phenotypes, suggesting the presence of additional factors that influence the expression of the disease (13).”
From X-linked adrenoleukodystrophy and primary adrenal insufficiency (2023) · cites this paper as [13]
In the citing paper
“It was recently reported that all male and possibly even most female patients will develop at least some symptoms of AMN late in life and thus AMN has a near 100% lifetime penetrance.12,14,23”
From The genetic landscape of X-linked adrenoleukodystrophy: inheritance, mutations, modifier genes, and diagnosis (2015) · cites this paper as [23]
Citations
Cites
The Metabolic and Molecular Bases of Inherited Disease
Scriver, R. C. (1995) · Medical Entomology and Zoology · Cited by 12,101
The metabolic and molecular bases of inherited disease
Chen, Y.-T. (2001) · Medical Entomology and Zoology · Cited by 6,928
Hematopoietic Stem Cell Gene Therapy with a Lentiviral Vector in X-Linked Adrenoleukodystrophy
Cartier, N., Hacein-Bey-Abina, S., Bartholomae, C. C., Veres, G., Schmidt, M., Kutschera, I., Vidaud, M., Abel, U., Dal-Cortivo, L., Caccavelli, L., et al. (2009) · Science · doi:10.1126/science.1171242 · Cited by 1,508
Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters
Mosser, J., Douar, A.-M., Sarde, C.-O., Kioschis, P., Feil, R., Moser, H., Poustka, A.-M., Mandel, J.-L., & Aubourg, P. (1993) · Nature · doi:10.1038/361726a0 · Cited by 1,202
Moser, H. W., Mahmood, A., & Raymond, G. V. (2007) · Nature Clinical Practice Neurology · doi:10.1038/ncpneuro0421 · Cited by 663
Engelen, M., Kemp, S., de Visser, M., van Geel, B. M., Wanders, R. J., Aubourg, P., & Poll-The, B. (2012) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-7-51 · Cited by 562
Self-citationAdrenoleukodystrophy: A Clinical and Pathological Study of 17 Cases
Schaumburg, H. H. (1975) · Archives of Neurology · doi:10.1001/archneur.1975.00490510033001 · Cited by 475
Qualitative alteration in substrate specificity of mitochondrial monoamine oxidase in brain
Moskvitina, T. A., Kamyshanskaya, N. S., Kaverina, L. P., & Gorkin, V. Z. (1976) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1976.tb04462.x · Cited by 440
Magnetic Resonance of Myelination and Myelin Disorders
van der Knaap, M. S., & Valk, J. (2005) · Springer eBooks · doi:10.1007/3-540-27660-2 · Cited by 397
Moser, H. (1981) · doi:10.1212/wnl.31.10.1241 · Cited by 396
Research works printed but not linked: 1
- Heubner O. Über diffuse Hirnsclerose. Charite Ann. 1897;22:298–310.
Cited by
Sorted by citations
Human disorders of peroxisome metabolism and biogenesis
Waterham, H. R., Ferdinandusse, S., & Wanders, R. J. A. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2015.11.015 · Cited by 384
The peroxisome: an update on mysteries 2.0
Islinger, M., Völkl, A., Fahimi, H. D., & Schrader, M. (2018) · Histochemistry and Cell Biology · doi:10.1007/s00418-018-1722-5 · Cited by 296
Adrenoleukodystrophy—Neuroendocrine pathogenesis and redefinition of natural history
Kemp, S., Huffnagel, I. C., Linthorst, G. E., Wanders, R. J., & Engelen, M. (2016) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.90 · Cited by 275
Self-citationLiu, X. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-7647-4_2 · Cited by 269
The physiological functions of human peroxisomes
Wanders, R. J. A., Baes, M., Ribeiro, D., Ferdinandusse, S., & Waterham, H. R. (2023) · Physiological Reviews · doi:10.1152/physrev.00051.2021 · Cited by 228
Liu, X. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-7647-4_3 · Cited by 231
Organelle interplay-peroxisome interactions in health and disease.
Schrader, M., Kamoshita, M., & Islinger, M. (2020) · Journal of Inherited Metabolic Disease · doi:10.1002/jimd.12083 · Cited by 149
Berger, J., Wiesinger, C., & Eichler, F. (2015) · The Application of Clinical Genetics · doi:10.2147/tacg.s49590 · Cited by 140
Vogel, B. H., Bradley, S. E., Adams, D. J., D'Aco, K., Erbe, R. W., Fong, C., Iglesias, A., Kronn, D., Levy, P., Morrissey, M., et al. (2015) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2015.02.002 · Cited by 123
From OPC to Oligodendrocyte: An Epigenetic Journey
Tiane, A., Schepers, M., Rombaut, B., Hupperts, R., Prickaerts, J., Hellings, N., van den Hove, D., & Vanmierlo, T. (2019) · Cells · doi:10.3390/cells8101236 · Cited by 128
IRF2BPL Is Associated with Neurological Phenotypes
Marcogliese, P. C., Shashi, V., Spillmann, R. C., Stong, N., Rosenfeld, J. A., Koenig, M. K., Martínez-Agosto, J. A., Herzog, M. R., Chen, A. H., Dickson, P., et al. (2018) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2018.07.006 · Cited by 115
Kemper, A. R., Brosco, J., Comeau, A. M., Green, N. S., Grosse, S. D., Jones, E., Kwon, J. M., Lam, W. K. K., Ojodu, J., Prosser, L. A., et al. (2017) · Genetics in Medicine · doi:10.1038/gim.2016.68 · Cited by 109
The structural basis of fatty acid elongation by the ELOVL elongases
Nie, L., Pascoa, T. C., Pike, A. C. W., Bushell, S. R., Quigley, A., Ruda, G. F., Chu, A., Cole, V., Speedman, D., Moreira, T., et al. (2021) · Nature Structural & Molecular Biology · doi:10.1038/s41594-021-00605-6 · Cited by 99
Fourcade, S., Ferrer, I., & Pujol, A. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.05.041 · Cited by 80
Koto, Y., Sakai, N., Lee, Y., Kakee, N., Matsuda, J., Tsuboi, K., Shimozawa, N., Okuyama, T., Nakamura, K., Narita, A., et al. (2021) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2021.05.004 · Cited by 55
Casasnovas, C., Ruíz, M., Schlüter, A., Naudí, A., Fourcade, S., Veciana, M., Castañer, S., Albertí, A., Bargalló, N., Johnson, M. R., et al. (2019) · Neurotherapeutics · doi:10.1007/s13311-019-00735-2 · Cited by 42
Successful donor engraftment and repair of the blood-brain barrier in cerebral adrenoleukodystrophy.
Orchard, P., Nascene, D., Miller, W. P., Gupta, A. O., Kenney-Jung, D. L., & Lund, T. C. (2019) · Blood · doi:10.1182/blood-2018-11-887240 · Cited by 33
Ogaki, K., Koga, S., Aoki, N., Lin, W.-L., Suzuki, K., Ross, O. A., & Dickson, D. W. (2015) · Neuropathology · doi:10.1111/neup.12230 · Cited by 35
Versatility of peroxisomes: An evolving concept
Deb, R., & Nagotu, S. (2017) · Tissue and Cell · doi:10.1016/j.tice.2017.03.002 · Cited by 33
Glial cells in the driver seat of leukodystrophy pathogenesis
Garcia, L., Hacker, J. L., Sase, S., Adang, L. A., & Almad, A. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.105087 · Cited by 34
Manor, J., Chung, H.-L., Bhagwat, P., & Wangler, M. F. (2021) · Journal of Neuroscience Research · doi:10.1002/jnr.24953 · Cited by 34
Pediatric Adrenal Insufficiency: Challenges and Solutions
Nisticò, D., Bossini, B., Benvenuto, S., Pellegrin, M. C., & Tornese, G. (2022) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s294065 · Cited by 35
X-linked adrenoleukodystrophy and primary adrenal insufficiency
Cappa, M., Todisco, T., & Bizzarri, C. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1309053 · Cited by 28
Imaging in X-Linked Adrenoleukodystrophy
van de Stadt, S. I. W., Huffnagel, I. C., Turk, B. R., van der Knaap, M. S., & Engelen, M. (2021) · Neuropediatrics · doi:10.1055/s-0041-1730937 · Cited by 30
Self-citationManagement of adrenoleukodystrophy: From pre-clinical studies to the development of new therapies
Ma, C. Y., Li, C., Zhou, X., Zhang, Z., Jiang, H., Liu, H., Chen, H. J., Tse, H., Liao, C., & Lian, Q. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112214 · Cited by 31
Antioxidant Capacity and Superoxide Dismutase Activity in Adrenoleukodystrophy
Turk, B. R., Theisen, B. E., Nemeth, C. L., Marx, J. S., Shi, X., Rosen, M. H., Jones, R. O., Moser, A. B., Watkins, P. A., Raymond, G. V., et al. (2017) · JAMA Neurology · doi:10.1001/jamaneurol.2016.5715 · Cited by 27
Bezine, M., Debbabi, M., Nury, T., Khalifa, R. B., Samadi, M. H., Cherkaoui‐Malki, M., Véjux, A., Raas, Q., Seze, J. D., Moreau, T., et al. (2017) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2017.03.006 · Cited by 27
Family Perspectives on Newborn Screening for X-Linked Adrenoleukodystrophy in California
Schwan, K., Youngblom, J. H., Weisiger, K., Kianmahd, J., Waggoner, R., & Fanos, J. H. (2019) · International Journal of Neonatal Screening · doi:10.3390/ijns5040042 · Cited by 26
Existing Evidence for the Repurposing of PARP-1 Inhibitors in Rare Demyelinating Diseases
Mekhaeil, M., Dev, K. K., & Conroy, M. J. (2022) · Cancers · doi:10.3390/cancers14030687 · Cited by 25
Newborn screening for adrenoleukodystrophy: International experiences and challenges
Videbæk, C. S., Melgaard, L., Lund, A. M., & Grønborg, S. W. (2023) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2023.107734 · Cited by 28
Erucic Acid: A Possible Therapeutic Agent for Neurodegenerative Diseases
Goyal, A., Dubey, N., Verma, A., & Agrawal, A. (2023) · Current Molecular Medicine · doi:10.2174/1566524023666230509123536 · Cited by 24
Therapeutic strategies in adrenoleukodystrophy
Turk, B. R., Moser, A. B., & Fatemi, A. S. (2017) · Wiener Medizinische Wochenschrift · doi:10.1007/s10354-016-0534-2 · Cited by 24
Leriglitazone halts disease progression in adult patients with early cerebral adrenoleukodystrophy
Golse, M., Weinhofer, I., Blanco, B., Barbier, M., Yazbeck, E., Huiban, C., Chaumette, B., Pichon, B., Fatemi, A., Pascual, S., et al. (2024) · Brain · doi:10.1093/brain/awae169 · Cited by 23
Coppa, A., Guha, S., Fourcade, S., Parameswaran, J., Ruiz, M., Moser, A. B., Schlüter, A., Murphy, M. P., Lizcano, J. M., Miranda-Vizuete, A., et al. (2020) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2020.01.177 · Cited by 23
Bergner, C. G., Genc, N., Hametner, S., Franz, J., van der Meer, F., Mitkovski, M., Weber, M. S., Stoltenburg‐Didinger, G., Kühl, J., Köhler, W., et al. (2021) · Glia · doi:10.1002/glia.24042 · Cited by 23
Gut dysmotility in children with neurological impairment: the nutritional management
Corsello, A., Scatigno, L., Govoni, A., Zuccotti, G., Gottrand, F., Romano, C., & Verduci, E. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1200101 · Cited by 26
Fernandes, J. F., Bonfim, C., Kerbauy, F. R., Rodrigues, M., Esteves, I., Silva, N. H., de Azambuja, A. M. P., Mantovani, L. F. A. L., Kutner, J. M., Loth, G., et al. (2018) · Bone Marrow Transplantation · doi:10.1038/s41409-017-0015-2 · Cited by 23
Wang, X. M., Yik, W. Y., Zhang, P., Lu, W., Huang, N., Kim, B. R., Shibata, D. K., Zitting, M., Chow, R. H.-P., Moser, A. B., et al. (2015) · Stem Cell Research & Therapy · doi:10.1186/s13287-015-0149-3 · Cited by 22
Redox Imbalance in Neurological Disorders in Adults and Children
Rey, F., Berardo, C., Maghraby, E., Mauri, A., Messa, L., Esposito, L., Casili, G., Ottolenghi, S., Bonaventura, E., Cuzzocrea, S., et al. (2023) · Antioxidants · doi:10.3390/antiox12040965 · Cited by 23
The pathology of X-linked adrenoleukodystrophy: Tissue specific changes as a clue to pathophysiology
Yska, H. A. F., Engelen, M., & Bugiani, M. (2024) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-024-03105-0 · Cited by 20
Self-citationSąsiadek, M. J. (2015) · Polish Journal of Radiology · doi:10.12659/pjr.893285 · Cited by 20
In Vivo NMR Studies of the Brain with Hereditary or Acquired Metabolic Disorders
Sherry, E. B., Lee, P., & Choi, I.-Y. (2015) · Neurochemical Research · doi:10.1007/s11064-015-1772-1 · Cited by 22
Compendium of causative genes and their encoded proteins for common monogenic disorders
Apgar, T. L., & Sanders, C. R. (2021) · Protein Science · doi:10.1002/pro.4183 · Cited by 21
The Role of Microglia in Inherited White-Matter Disorders and Connections to Frontotemporal Dementia
Sirkis, D. W., Bonham, L. W., & Yokoyama, J. S. (2021) · The Application of Clinical Genetics · doi:10.2147/tacg.s245029 · Cited by 21
Molecular Biomarkers in Multiple Sclerosis and Its Related Disorders: A Critical Review
Gul, M., Jafari, A. A., Shah, M., Mirmoeeni, S., Haider, S. U., Moinuddin, S., & Chaudhry, A. A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176020 · Cited by 17
ABCD1 Gene Mutations: Mechanisms and Management of Adrenomyeloneuropathy
Volmrich, A. M., Cuénant, L. M., Forghani, I., Hsieh, S. L., & Shapiro, L. T. (2022) · The Application of Clinical Genetics · doi:10.2147/tacg.s359479 · Cited by 19
Leukodystrophy imaging: Insights for diagnostic dilemmas.
Thakkar, R. N., Patel, D., Kioutchoukova, I. P., Al-Bahou, R., Reddy, P., Foster, D. T., & Lucke-Wold, B. (2024) · Medical Sciences · doi:10.3390/medsci12010007 · Cited by 17
An overview of inborn errors of metabolism manifesting with primary adrenal insufficiency
Hannah‐Shmouni, F., & Stratakis, C. A. (2018) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-018-9447-2 · Cited by 17
Computational insight into structural basis of human ELOVL1 inhibition
Siddiqui, A. J., Kumar, V., Jahan, S., Alshahrani, M. M., Awadh, A. A. A., Siddiqui, M. A., Hamadou, W. S., Abdelgadir, A., Saxena, J., Badraoui, R., et al. (2023) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2023.106786 · Cited by 16
Insights Into the Peroxisomal Protein Inventory of Zebrafish
Kamoshita, M., Kumar, R., Anteghini, M., Kunze, M., Islinger, M., dos Santos, V. A. P. M., & Schrader, M. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.822509 · Cited by 16
Alarcan, H., Ojaimi, Y. A., Lanznaster, D., Escoffre, J., Corcia, P., Vourc’h, P., Andres, C. R., Veyrat‐Durebex, C., & Blasco, H. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12071071 · Cited by 17
Willemsen, M. A. A. P., Harting, I., & Wevers, R. A. (2016) · Neurology Clinical Practice · doi:10.1212/cpj.0000000000000266 · Cited by 15
Adrenoleukodystrophy in the era of newborn screening
Eng, L., & Regelmann, M. O. (2019) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000515 · Cited by 15
Imbalanced mitochondrial dynamics contributes to the pathogenesis of X-linked adrenoleukodystrophy
Launay, N., Lopez-Erauskin, J., Bianchi, P., Guha, S., Parameswaran, J., Coppa, A., Torreni, L., Schlüter, A., Fourcade, S., Paredes-Fuentes, A. J., et al. (2024) · Brain · doi:10.1093/brain/awae038 · Cited by 14
Dong, B., Lv, W., Xu, L., Zhao, Y., Sun, X., Wang, Z., Cheng, B., Fu, Z., & Wang, Y. (2022) · International Journal of Endocrinology · doi:10.1155/2022/5479781 · Cited by 12
Primary and Secondary Hypogonadism
Santi, D., & Corona, G. (2017) · Endocrinology · doi:10.1007/978-3-319-44441-3_24 · Cited by 14
Strategy for genetic analysis in hereditary neuropathy
Masingue, M., Fernández‐Eulate, G., Debs, R., Tard, C., Labeyrie, C., Léonard-Louis, S., Dhaenens, C., Masson, M. L. P., Latour, P., & Stojkovic, T. (2022) · Revue Neurologique · doi:10.1016/j.neurol.2022.11.007 · Cited by 12
Kornbluh, A. B., Baldwin, A., Fatemi, A. S., Vanderver, A. L., Adang, L. A., van Haren, K. P., Sampson, J. B., Eichler, F., Sadjadi, R., Engelen, M., et al. (2024) · Neurology Genetics · doi:10.1212/nxg.0000000000200192 · Cited by 13
Self-citationIntracerebral lentiviral ABCD1 gene therapy in an early disease onset ALD mouse model
Gong, J., Liu, Y., Chung, T., Xu, L., Lund, T. C., & Chang, L. (2022) · Gene Therapy · doi:10.1038/s41434-022-00355-0 · Cited by 12
Lund, T. C., Ng, M., Orchard, P. J., Loes, D. J., Raymond, G. V., Gupta, A., Kenny-Jung, D., & Nascene, D. R. (2020) · Biology of Blood and Marrow Transplantation · doi:10.1016/j.bbmt.2020.06.019 · Cited by 12
Intrathecal baclofen treatment an option in X-linked adrenoleukodystrophy
Hjartarson, H. T., Ehrstedt, C., & Tedroff, K. (2017) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2017.09.003 · Cited by 11
Broadening the Spectrum of Adulthood X-Linked Adrenoleukodystrophy: A Report of Two Atypical Cases
Foschi, M., Vacchiano, V., Avoni, P., Incensi, A., Battaglia, S., Donadio, V. A., Panzeri, E., Bassi, M. T., Liguori, R., & Rizzo, G. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00070 · Cited by 11
Pearls & Oy-sters: Adolescent-onset adrenomyeloneuropathy and arrested cerebral adrenoleukodystrophy
Lin, J. E., Armour, E. A., Heshmati, A., Umandap, C. H., Couto, J. J., Iglesias, A. D., Mallack, E. J., & Bain, J. (2019) · Neurology · doi:10.1212/wnl.0000000000007755 · Cited by 10
Adanyeguh, I. M., Lou, X., McGovern, E. M., Luton, M., Barbier, M., Yazbeck, E., Valabrègue, R., Deelchand, D. K., Henry, P., & Mochel, F. (2021) · NeuroImage Clinical · doi:10.1016/j.nicl.2021.102566 · Cited by 10
Costei, C., Barbarosie, M., Bernard, G., Brais, B., & Piana, R. L. (2021) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.20110294 · Cited by 10
Dong, L.-W., Xiao, J., Liu, S., Deng, G., Liao, Y.-C., Chu, B., Zhao, X., Song, B., & Luo, J. (2023) · Science China Life Sciences · doi:10.1007/s11427-022-2260-4 · Cited by 10
Natarajan, A., Christopher, R., Netravathi, M., Bhat, M. D., & Chandra, S. R. (2019) · Clinica Chimica Acta · doi:10.1016/j.cca.2019.04.059 · Cited by 10
Inborn Errors of Metabolism with Ataxia: Current and Future Treatment Options
Brémovà-Ertl, T., Hofmann, J. C., Stucki, J. W., Vossenkaul, A., & Gautschi, M. (2023) · Cells · doi:10.3390/cells12182314 · Cited by 10
Lysosomal membrane contact sites: Integrative hubs for cellular communication and homeostasis
Bandyopadhyay, S., Adebayo, D., Obaseki, E., & Hariri, H. H. (2024) · Current topics in membranes · doi:10.1016/bs.ctm.2024.07.001 · Cited by 9
Yska, H. A. F., Turk, B. R., Fatemi, A. S., Goodman, J., Voermans, M. M. C., Amos, D., Amanat, M., van de Stadt, S. I. W., Engelen, M., Fine, A. S., et al. (2024) · Journal of Inherited Metabolic Disease · doi:10.1002/jimd.12753 · Cited by 9
Self-citationLate onset adrenoleukodystrophy: A review related clinical case report
Paláu-Hernández, S., Rodríguez‐Leyva, I., & Shiguetomi-Medina, J. M. (2019) · eNeurologicalSci · doi:10.1016/j.ensci.2019.01.007 · Cited by 8
Pan, E., Tao, F., Smorodina, E., & Zhang, S. (2024) · QRB Discovery · doi:10.1017/qrd.2024.2 · Cited by 8
In vivo adenine base editing rescues adrenoleukodystrophy in a humanized mouse model
Gopalappa, R., Lee, M., Kim, G., Jung, E. S., Lee, H., Hwang, H.-Y., Lee, J. G., Kim, S. J., Yoo, H. J., Sung, Y. H., et al. (2024) · Molecular Therapy · doi:10.1016/j.ymthe.2024.05.027 · Cited by 8
An unusual presentation of X-linked adrenoleukodystrophy
Suryawanshi, A., Middleton, T. L., & Ganda, K. (2015) · Endocrinology Diabetes and Metabolism Case Reports · doi:10.1530/edm-15-0098 · Cited by 8
Magnetic resonance spectroscopy as marker for neurodegeneration in X-linked adrenoleukodystrophy
van de Stadt, S. I. W., Schrantee, A., Huffnagel, I. C., van Ballegoij, W. J. C., Caan, M. W. A., Pouwels, P. J. W., & Engelen, M. (2021) · NeuroImage Clinical · doi:10.1016/j.nicl.2021.102793 · Cited by 7
Self-citationYue, X., Liu, W., Liu, Y., Shen, M., Zhai, Y., Ma, Z., & Cao, Z. (2021) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.24099 · Cited by 6
Moser, A. B., Liu, Y., Shi, X., Schrifl, U., Hiebler, S., Fatemi, A. S., Braverman, N., Steinberg, S. J., & Watkins, P. A. (2021) · Journal of Cellular Biochemistry · doi:10.1002/jcb.30014 · Cited by 7
Fatty Acid Metabolism in Peroxisomes and Related Disorders
Morito, K., Ali, H., Kishino, S., & Tanaka, T. (2024) · Advances in experimental medicine and biology · doi:10.1007/5584_2024_802 · Cited by 6
Proteasome-dependent protein quality control of the peroxisomal membrane protein Pxa1p
Devarajan, S., Meurer, M., van Roermund, C. W. T., Chen, X., Hettema, E. H., Kemp, S., Knop, M., & Williams, C. (2020) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2020.183342 · Cited by 6
Self-citationPain Study in X-Linked Adrenoleukodystrophy in Males and Females
Bachiocco, V., Cappa, M., Petroni, A., Salsano, E., Bizzarri, C., Ceccarelli, I., Cevenini, G., Pensato, V., & Aloisi, A. M. (2021) · Pain and Therapy · doi:10.1007/s40122-021-00245-0 · Cited by 6
Movement Disorders and Inherited Metabolic Disorders
(2020) · Cambridge University Press eBooks · doi:10.1017/9781108556767 · Cited by 6
Fujitani, N., Saito, M., Akashi, T., Morita, M., So, T., & Oka, K. (2022) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b22-00506 · Cited by 5
The experiences of parents of children diagnosed with cerebral adrenoleukodystrophy
Piercy, H., & Nutting, C. (2023) · Child Care Health and Development · doi:10.1111/cch.13184 · Cited by 5
Diffusion Tensor Imaging in Boys With Adrenoleukodystrophy
Pierpont, E. I., Labounek, R., Gupta, A. O., Lund, T. C., Orchard, P. J., Dobyns, W. B., Bondy, M. T., Paulson, A. L., Metz, A., Shanley, R., et al. (2024) · Neurology · doi:10.1212/wnl.0000000000209764 · Cited by 5
Videbæk, C. S., Grønborg, S. W., Lund, A. M., & Olesen, M. L. (2024) · International Journal of Neonatal Screening · doi:10.3390/ijns10040073 · Cited by 5
Olgaç, A., Kasapkara, Ç. S., Derinkuyu, B. E., Yüksel, D., Çetinkaya, S. Ç., Aksoy, A., Ceylaner, S., Lafcı, N. G., Yeşilipek, A., Aydın, H. İ., et al. (2021) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2021-0032 · Cited by 5
Genetic diseases mimicking multiple sclerosis
Hsu, C. L., Iwanowski, P. S., Hsu, C. H., & Kozubski, W. P. (2021) · Postgraduate Medicine · doi:10.1080/00325481.2021.1945898 · Cited by 8
Typical and atypical phenotype and neuroimaging of X-linked adrenoleukodystrophy in a Chinese cohort
Mao, C., Li, J., Huang, X., Wang, J., Chu, S., Zhang, Y., Dong, L., Liu, C., Lü, L., Qiu, L., et al. (2022) · Neurological Sciences · doi:10.1007/s10072-021-05859-y · Cited by 5
Wang, D., Yu, S., Zhang, Y., Yin, Y., Cheng, Q., Xie, S., Yu, J., Li, H., Cheng, X., & Qiu, L. (2019) · Clinica Chimica Acta · doi:10.1016/j.cca.2019.04.058 · Cited by 5
Videbæk, C. S., Dunø, M., Lindquist, S. G., Larsen, V. A., Kjær, M. W., Melgaard, L., Nielsen, J. E., Grønborg, S. W., & Lund, A. M. (2025) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2025.109265 · Cited by 5
S149R, a novel mutation in theABCD1gene causing X-linked adrenoleukodystrophy
Yan, F., Wang, W., Ying, H., Li, H., Chen, J., & Xu, C. (2017) · Oncotarget · doi:10.18632/oncotarget.20974 · Cited by 5
Al‐Essa, M., & Dhaunsi, G. S. (2019) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2018-0540 · Cited by 4
Adrenoleucodistrofia ligada a X: Un caso de presentación aguda cerebral infantil
Bustos, S., Charry, M. L., & Espinosa, E. (2021) · Andes pediatrica · doi:10.32641/andespediatr.v92i4.3345 · Cited by 5
Easily misdiagnosed X-linked adrenoleukodystrophy
Wang, Q., Wang, Y., Wang, J., Liu, L.-Y., Gao, J., Hao, G.-Z., Chen, C., Lü, Q., Dun, S., Zhang, Q., et al. (2024) · The Italian Journal of Pediatrics/Italian journal of pediatrics · doi:10.1186/s13052-024-01669-y · Cited by 6
Primary and Secondary Hypogonadism
Santi, D., & Corona, G. (2017) · Endocrinology · doi:10.1007/978-3-319-29456-8_24-1 · Cited by 4
Intrathecal administration of mesenchymal stem cells in patients with adrenomyeloneuropathy
Siwek, T., Zwiernik, B., Jezierska‐Woźniak, K., Jezierska, K., Mycko, M. P., & Selmaj, K. W. (2024) · Frontiers in Neurology · doi:10.3389/fneur.2024.1345503 · Cited by 4
Shim, Y. J., Shin, M. K., Jung, J., Koo, B., & Jang, W. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.996698 · Cited by 5
Wang, P., Du, X., Shen, Q., Jiang, W., Shen, C., Wang, H., Zhou, S., Wang, Y., Qian, X., & Zhai, X. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.999919 · Cited by 3
Accelerated Course of Cerebral Adrenoleukodystrophy After Coronavirus Disease 2019 Infection
Wang, Q., Wang, J., Wang, Y., He, W., Chen, F., Gao, J., Lu, Q., Wang, Y., Dun, S., Zhang, Q., et al. (2024) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2023.12.021 · Cited by 3
Metadata
- Authors
- Engelen, M., Kemp, S., & Poll-The, B.-T.
- Affiliations
- Amsterdam UMC Location University of Amsterdam (NL)
- Venue
- Current Neurology and Neuroscience Reports
- Published
- 2014-08-13
- Volume
- 14
- Issue
- 10
- Pages
- 486-486
- ISSN
- 1528-4042 (ISSN-L)
- 1534-6293
- OpenAlex
- W2081051956
- Cited by
- 187
- References
- 84
- Citations by year
- 2026: 7 · 2025: 10 · 2024: 33 · 2023: 19 · 2022: 18 · 2021: 25 · 2020: 18 · 2019: 18 · 2018: 7 · 2017: 15 · 2016: 6 · 2015: 10
- FWCI
- 1.31
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Current Neurology and Neuroscience Reports (publishedVersion)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (publishedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Health Sciences › Medicine › Genetics (clinical) › Lysosomal Storage Disorders Research
- Life Sciences › Neuroscience › Neurology › Neurological diseases and metabolism
- Keywords
- X-linked adrenoleukodystrophy, ABCD1 gene, very long chain fatty acids, inborn errors of metabolism, adrenal insufficiency, cerebral adrenoleukodystrophy, myelopathy, peripheral neuropathy, brain demyelination, pathogenesis, treatment options
- MeSH terms
- ATP Binding Cassette Transporter, Subfamily D, Member 1, Addison Disease, Adrenoleukodystrophy, Humans, Mutation, Peripheral Nervous System Diseases, Spinal Cord Diseases, Disease Progression, ATP-Binding Cassette Transporters
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review